Skip to main content

Animations

MJFF Publications

4141 - 4150 of 8823 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2023
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: A connectomics-based taxonomy of mammals
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.78635
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson’s Disease — The RESISTA-PD Trial
    Journal Name: Genomics, Proteomics & Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.gpb.2021.08.009
    Citation Count: 93
  • Summary Details
    OPEN
    Title: Integrating multi-omics summary data using a Mendelian randomization framework
    Journal Name: Briefings in Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bib/bbac376
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03965-x
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Stability of motor-nonmotor subtype in early-stage Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1040405
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.1036068
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines11020573
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29215
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Progression of regional cortical cholinergic denervation in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac320
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01494-6
    Citation Count: 115
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.